0.000
0.00 (0.00%)
AIStockmoo 评分
| 价值 | NA |
| 来自我们的 AI Insight 报告对预期回报与风险的评估。 参考 | NA |
| 相对估值 参考 | NA |
| 隐含增长 参考 | NA |
| 历史估值 参考 | NA |
| 资本回报 参考 | NA |
| 财务健康 参考 | NA |
| 盈利趋势 参考 | NA |
| 持仓估值 参考 | NA |
| 风险溢价 参考 | NA |
| 市场估值 参考 | NA |
| 时机 | NA |
| 来自我们对走势图的 AI 技术分析。 参考 | NA |
| 趋势强度 参考 | NA |
| 技术形态 参考 | NA |
| K线形态 参考 | NA |
| 中期趋势 参考 | NA |
| 市场情绪 100% | 0.0 |
| 近期没有目标价,因此依据目标价的调整方向。 参考 | |
| 持仓情绪 参考 | NA |
| 新闻情绪 参考 | NA |
| 聪明钱 | NA |
| 内部交易活动 参考 | NA |
| 机构资金流 参考 | NA |
| 市场和行业状况不佳。 | |
| 市场环境偏谨慎。 参考 | |
| 行业表现落后大市。 | |
| 没有支柱有明确读数,评分不变。 | |
| 不计入评分 | |
| 价格波动 参考 | NA |
| 短、中、长期均无明确趋势。 参考 | |
| 支撑与阻力没有明确信号。 参考 | |
| 最终评分 | 0.00 |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看涨 |
| Biotechnology (全球的) | 混合的 | 看涨 | |
| 股票 | Timber Pharmaceuticals, Inc. | - | - |
相关股票
| 股票 | 市值 | DY | P/E(TTM) | P/B | 评分 |
|---|---|---|---|---|---|
| TMBR | - | - | - | - | 0.0 |
| CYBN | 359 M | - | - | - | 0.0 |
| LCTX | 195 M | - | - | 2.91 | -2.3 |
| NRXS | 60 M | - | - | 18.58 | -1.2 |
| CVM | 21 M | - | - | 2.22 | -3.7 |
| NHWK | 20 M | - | - | 0.260 | 0.0 |
|
Timber Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for orphan dermatologic diseases. The company's lead product candidates include TMB-001, a patented topical formulation of isotretinoin that has completed Phase 2b clinical trial for the treatment of moderate to severe subtypes of CI, a group of rare genetic keratinization disorders; and TMB-003, a proprietary formulation of Sitaxsentan, which is a selective endothelin-A receptor antagonist that is in preclinical development for the treatment of sclerotic skin diseases. It is also involved in the development of BPX-01, which is in Phase 3 topical minocycline for the treatment of inflammatory lesions of acne vulgaris; and BPX-04 that is a Phase 3 ready topical minocycline for the treatment of papulopustular rosacea. The company was founded in 2019 and is headquartered in Warren, New Jersey. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
该时间范围内无数据。
该时间范围内无数据。
投资组合